Cytolytic response to HIV in patients with HIV disease treated with extracorporeal photochemotherapy: Preliminary study

Photochemistry and Photobiology

Volumn 63, Issue 5, 1996, Pages 558-561

  Gonzalez, Joselyn ^a   Berger, Carole ^b   Cottrill, Carolyn M ^a   Geller, Alex ^c   Schwartz, Joseph ^a   Palangio, Mark ^d   Klainer, Albert S ^a,d   Bisaccia, Emil ^a,b,d,e  

^a MORRISTOWN MEMORIAL HOSPITAL   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MAYO CLINIC   (United States)

^d College of Physicians and Surgeons ^*  (United States)

^e Department of Photopheresis ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN HERPESVIRUS 4; HUMAN IMMUNODEFICIENCY VIRUS; VACCINIA;

GAG PROTEIN; VIRUS ENVELOPE PROTEIN;

ADULT; ARTICLE; BIOSYNTHESIS; CD4 LYMPHOCYTE COUNT; CLINICAL TRIAL; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; MALE; MIDDLE AGED; NATURAL KILLER CELL; PUVA;

ADULT; CD4 LYMPHOCYTE COUNT; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; FOLLOW-UP STUDIES; GENE PRODUCTS, ENV; GENE PRODUCTS, GAG; HIV; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; KILLER CELLS, NATURAL; MALE; MIDDLE AGED; PHOTOPHERESIS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0030136546     PISSN: 00318655     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1751-1097.1996.tb05655.x     Document Type: Conference Paper

References (29)

1. Dubertret, L., D Averbeck, E. Bisagni, J. Moron, E. Moustacchi, C. Billardon, D. Papadopoulo, S. Nocentini, P. Vigny and J. Blais (1985) Photochemotherapy using pyridopsoralens. Biochimie 67, 417-422.
2. Edelson, R., C Berger, F. Gasparro, B. Jegasothy, P. Heald, B. Wintroub, E. Vonderheid, R. Knobler, K. Wolff, G. Plewig, G. McKiernan, I. Christiansen, M. Oster, H. Honigsmann, H. Wilford, E. Kokoschka, T. Rehle, M. Perez, G Stingl and L. Laroche (1987) Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results. N. Engl. J. Med. 316, 297-303.
3. Rook, A. H., B. V. Jegasothy, P. Heald, G. T. Nahass, C. Ditre, W. K. Witmer, G S. Lazarus and R. L. Edelson (1990) Extracorporeal photochemotherapy for drug-resistant pemphigus vulgaris. Ann. Intern. Med. 112, 303-305.
4. Malawista, S. E., D. H. Trock and R. L. Edelson (1991) Treatment of rheumatoid arthritis by extracorporeal photochemotherapy. A pilot study Arthritis Rheum. 34, 646-654.
5. Knobler, R. M., W. Graninger, W. Graninger, A. Lindmaier, F. Trautinger and J. S. Smolen (1992) Extracorporeal photochemotherapy for the treatment of systemic lupus erythematosus. A pilot study. Arthritis Rheum. 35, 319-324.
6. Rook, A. H., B. Freundlich, B. V. Jegasothy, M. I. Perez, W. G. Barr, S. A. Jimenez, R. L. Rietschel, B. Wintroub, M. B. Kahaleh, J. Varga, P. W. Heald, V. Steen, M. C. Massa, G. F. Murpthy, C. Perniciaro, M. Istfan, S. K. Ballas and R. L. Edelson (1992) Treatment of systemic sclerosis with extracorporeal photochemotherapy: results of a multicenter trial. Arch. Dermatol. 128, 337-346
7. Costanzo-Nordin, M. R., E. A. Hubbell, E. J. O'Sullivan, M. R. Johnson, G. M. Mullen, A. L. Heroux, W. G. Kao, B. M. McManus, R. Pifarre and J. A. Robinson (1992) Successful treatment of heart transplant rejection with photopheresis. Transplant 53, 808-815.
8. Slovis, B. S., J. E. Loyd and L. E. King, Jr. (1995) Photopheresis for chronic rejection of lung allograft. N. Engl. J. Med. 332, 962.
9. Bisaccia, E., C. Berger and A. S. Klainer (1990) Extracorporeal photopheresis in the treatment of AIDS-related complex: a pilot study. Ann. Intern. Med. 113, 270-275.
10. Bisaccia, E., C. Berger, F. DiSpaltro and A. S. Klainer (1993) Extracorporeal photopheresis in the treatment of AIDS-related complex: extended trial. J. Acquired Immune Defic. Syndr. 6, 386-392.
11. Quinnan, G. V., Jr., M. A. Wells, A. E. Wittek, M. A. Phelan, R. E. Mayner, S. Feinstone, R. H. Purcell and J. S. Epstein (1986) Inactivation of human T-cell lymphotrophic virus, type III by heat, chemicals, and irradiation. Transfusion 26, 481-483.
12. Watson, A. J., J. Klanieki and C. V. Hanson (1990) Psoralen/ UV inactivation of HIV-1-infected cells for use in cytologic and immunologic procedures. AIDS Res. Hum. Retroviruses 6, 503-512.
13. Lerner, A. B., C. R. Demon and T. B. Fitzpatrick (1953) Clinical and experimental studies with 8-methoxypsoralen in vitiligo. J. Invest. Dermatol 220, 299-314.
14. Celis, E., I Kato, R. W. Miller and T. W. Chang (1985) Regulation of the human immune response to HBsAg: effects of antibodies and antigen conformation in the stimulation of helper T cells by HBaAG. Hepatology 5, 744-751
15. Celis, E. and T. W. Chang (1984) HBsAg-serum protein complexes stimulate immune T lymphocytes more efficiently than do pure HBsAg. Hepatology 4, 1116-1123.
16. Safrit, J. T. and R. A. Koup (1995) The immunology of primary HIV infection: which immune responses control HIV replication? Curr. Opin. Immunol. 7, 456-461.
17. Plata, F., P. Langlade-Demoyen, J. P. Abastado, T. Berbar and P. Kourilsky (1987) Retrovirus antigens recognized by cytolytic T lymphocytes activate tumor rejection in vivo. Cell 48, 231-240.
18. Walker, B. D., S. Chakrabarti, B. Moss, T. J. Paradis, T. Flynn, A. G. Durno, R. S. Blumberg, J. C. Kaplan, M. S. Hirsch and R. T. Schooley (1988) HIV-specific cytotoxic T lymphocytes in seropositive individuals. Nature 328, 345-348.
19. Dadaglio, G., F. Michel, P. Langlade-Demoyen, P. Sansonetti, D. Chevrier, F. Vuillier, F. Plata and A. Hoffenbach (1992) Enhancement of HIV-specific cytotoxic T lymphocyte responses by zidovudine (AZT) treatment. Clin. Exp. Immunol. 87, 7-14.
20. Walker, B D. and F. Plata (1990) Cytotoxic T lymphocytes against HIV. AIDS 4, 177-184.
21. Plata, F. (1992) Implications of HIV-specific cytotoxic T lymphocytes in AIDS. Biotherapy 5, 31-45.
22. Carmichael, A., X. Jin, P. Sissons and L. Borysiewicz (1993) Quantitative analysis of human immunodefieincy virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease. J. Exp. Med. 177, 249-256.
23. + T lymphocytes of patients with AIDS maintain normal broad cytolytic function despite the loss of human immunodeficiency virus-specific cytotoxicity. Proc. Natl. Acad. Sci. USA 87, 4818-4822.
24. Redfield, R. R., D. C. Wright and E. C. Tramont (1986) The Walter Reed staging classification for HTLV-III/LAV infection. N. Engl. J. Med. 314, 131-132.
25. 51Cr labeled allogeneic target cells in vitro; inhibition by isoantibody and by drugs, Immunology 14, 181-196.
26. Lieberman, J., J. A. Fabry, P. Shankar, L. Beckett and P. R. Skolnik (1995) Ex vivo expansion of HIV type 1-specific cytolytic T cells from HIV type 1-seropositive subsets. AIDS Res. Hum. Retroviruses 11, 257-265.
27. Redfield, D. C., D. D. Richman, M. N. Oxman and L. H. Kronenberg (1981) Psoralen inactivation of influenza and herpes simplex viruses and of virus-infected cells. Infect. Immun. 32, 1216-1226.
28. Berger, C. L., M. Perez, L. Laroche and R. Edelson (1990) Inhibition of autoimmune disease in a murine model of systemic lupus erythematosus induced by exposure to syngeneic photoinactivated lymphocytes. J. Invest. Dermatol. 94, 52-57.
29. Perez, M. I., R. L. Edelson, L. L. Laroche and C. L. Berger (1989) Inhibition of anti-skin aliograft immunity by infusions with photoinactivated effector T lymphocytes (PET cells). Yale J. Biol Med. 62, 595-609.